Get started online in minutes
Press release: Novo Nordisk presents four new analyses on oral semaglutide 25 mg (Wegovy in a pill ) at ObesityWeek 2025, including demonstrated reductions in cardiovascular risk factors.* Retrieved from Rosenstock, J., Hsia, S., Ruiz, L
A new study suggests a potential connection between semaglutide use and an increased risk of non-arteritic anterior ischemic optic neuropathy (NAION), a blinding eye disease
When you eat, the hormone triggers the production of insulin and sends your brain signals that youre full
More recently, weve seen even more weight loss obtained with the drug Tirzepatide, he said, adding that its approved for Type 2 diabetes in the U.S
Maintaining a balanced diet and regular meal schedule also helps stabilize blood sugar levels, minimizing headache triggers